- Abstract
- 10.1016/j.revmed.2022.03.026
Analyse des discussions des patients atteints de lupus à partir des forums publics de l’internet en France
- Jun 01, 2022
- La Revue de Médecine Interne
- M Riviere + 2 more +2
Publications from 2021 to 2026
Showing 10 of 10 papers
Analyse des discussions des patients atteints de lupus à partir des forums publics de l’internet en France
PMH13 - Schizophrenia: Study of Epidemiological and Economic Regional Disparities
Patients' perspectives on residual symptoms in bipolar disorder: a focus group study.
Euthymic bipolar patients are often impacted by residual symptoms (RSs) that increase the risk of relapse or low functioning. We aimed to identify the perceptions of RSs, barriers to management, and service needs in euthymic bipolar patients. A qualitative methodology (focus group) was used. The interviews were investigated using a semistructured guide, tape-recorded, transcribed verbatim, and analyzed thematically. Twenty-three bipolar patients expressed concern about several RSs, such as emotional dysregulation, circadian rhythm disruption, cognitive impairment, low self-esteem, and physical symptoms. They reported concern about the impact of RSs on their functioning and about the need for more systematic assessment of RSs during interepisode visits. Selection bias may have occurred because the recruitment was limited to France and there may be cultural differences in the perceptions of RSs. Bipolar patients experienced bipolar disorder as a chronic disorder because they frequently continued to suffer from RSs associated with a functional impact.
Read morePW01-36 - The long-term safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar I patients partially non-responsive to mood stabilisers
P01-58 - Adjunctive aripiprazole in patients with major depressive disorder: pooled data on functioning from three clinical trials
P01-39 - Adjunctive aripiprazole in patients with major depressive disorder: efficacy data from three short-term studies
P01-38 - Efficacy of adjunctive aripiprazole in patients with major depressive disorder: pooled analysis of subgroup data from three clinical trials
P01-57 - Analysis of pooled safety data from three randomized, double-blind, placebo-controlled studies of adjunctive aripiprazole in major depressive disorder
P03-182 A 16-week, multicentre, randomized, open-label study assessing effects of aripiprazole versus other atypicals for schizophrenia patients with metabolic syndrome
Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: Results from the STAR study